1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Long-acting Injectable Medications Market Size Growth Rate by Type: 2016 VS 2021 VS 2027 1.2.2 First-generation 1.2.3 Second-generation 1.3 Market by Application 1.3.1 Global Long-acting Injectable Medications Market Share by Application: 2016 VS 2021 VS 2027 1.3.2 Schizophrenia 1.3.3 Contraception 1.3.4 HIV 1.3.5 Others 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Long-acting Injectable Medications Market Perspective (2016-2027) 2.2 Long-acting Injectable Medications Growth Trends by Regions 2.2.1 Long-acting Injectable Medications Market Size by Regions: 2016 VS 2021 VS 2027 2.2.2 Long-acting Injectable Medications Historic Market Share by Regions (2016-2021) 2.2.3 Long-acting Injectable Medications Forecasted Market Size by Regions (2022-2027) 2.3 Long-acting Injectable Medications Industry Dynamic 2.3.1 Long-acting Injectable Medications Market Trends 2.3.2 Long-acting Injectable Medications Market Drivers 2.3.3 Long-acting Injectable Medications Market Challenges 2.3.4 Long-acting Injectable Medications Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Long-acting Injectable Medications Players by Revenue 3.1.1 Global Top Long-acting Injectable Medications Players by Revenue (2016-2021) 3.1.2 Global Long-acting Injectable Medications Revenue Market Share by Players (2016-2021) 3.2 Global Long-acting Injectable Medications Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by Long-acting Injectable Medications Revenue 3.4 Global Long-acting Injectable Medications Market Concentration Ratio 3.4.1 Global Long-acting Injectable Medications Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Long-acting Injectable Medications Revenue in 2020 3.5 Long-acting Injectable Medications Key Players Head office and Area Served 3.6 Key Players Long-acting Injectable Medications Product Solution and Service 3.7 Date of Enter into Long-acting Injectable Medications Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Long-acting Injectable Medications Breakdown Data by Type 4.1 Global Long-acting Injectable Medications Historic Market Size by Type (2016-2021) 4.2 Global Long-acting Injectable Medications Forecasted Market Size by Type (2022-2027) 5 Long-acting Injectable Medications Breakdown Data by Application 5.1 Global Long-acting Injectable Medications Historic Market Size by Application (2016-2021) 5.2 Global Long-acting Injectable Medications Forecasted Market Size by Application (2022-2027) 6 North America 6.1 North America Long-acting Injectable Medications Market Size (2016-2027) 6.2 North America Long-acting Injectable Medications Market Size by Type 6.2.1 North America Long-acting Injectable Medications Market Size by Type (2016-2021) 6.2.2 North America Long-acting Injectable Medications Market Size by Type (2022-2027) 6.2.3 North America Long-acting Injectable Medications Market Size by Type (2016-2027) 6.3 North America Long-acting Injectable Medications Market Size by Application 6.3.1 North America Long-acting Injectable Medications Market Size by Application (2016-2021) 6.3.2 North America Long-acting Injectable Medications Market Size by Application (2022-2027) 6.3.3 North America Long-acting Injectable Medications Market Size by Application (2016-2027) 6.4 North America Long-acting Injectable Medications Market Size by Country 6.4.1 North America Long-acting Injectable Medications Market Size by Country (2016-2021) 6.4.2 North America Long-acting Injectable Medications Market Size by Country (2022-2027) 6.4.3 United States 6.4.4 Canada 7 Europe 7.1 Europe Long-acting Injectable Medications Market Size (2016-2027) 7.2 Europe Long-acting Injectable Medications Market Size by Type 7.2.1 Europe Long-acting Injectable Medications Market Size by Type (2016-2021) 7.2.2 Europe Long-acting Injectable Medications Market Size by Type (2022-2027) 7.2.3 Europe Long-acting Injectable Medications Market Size by Type (2016-2027) 7.3 Europe Long-acting Injectable Medications Market Size by Application 7.3.1 Europe Long-acting Injectable Medications Market Size by Application (2016-2021) 7.3.2 Europe Long-acting Injectable Medications Market Size by Application (2022-2027) 7.3.3 Europe Long-acting Injectable Medications Market Size by Application (2016-2027) 7.4 Europe Long-acting Injectable Medications Market Size by Country 7.4.1 Europe Long-acting Injectable Medications Market Size by Country (2016-2021) 7.4.2 Europe Long-acting Injectable Medications Market Size by Country (2022-2027) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic 8 Asia-Pacific 8.1 Asia-Pacific Long-acting Injectable Medications Market Size (2016-2027) 8.2 Asia-Pacific Long-acting Injectable Medications Market Size by Type 8.2.1 Asia-Pacific Long-acting Injectable Medications Market Size by Type (2016-2021) 8.2.2 Asia-Pacific Long-acting Injectable Medications Market Size by Type (2022-2027) 8.2.3 Asia-Pacific Long-acting Injectable Medications Market Size by Type (2016-2027) 8.3 Asia-Pacific Long-acting Injectable Medications Market Size by Application 8.3.1 Asia-Pacific Long-acting Injectable Medications Market Size by Application (2016-2021) 8.3.2 Asia-Pacific Long-acting Injectable Medications Market Size by Application (2022-2027) 8.3.3 Asia-Pacific Long-acting Injectable Medications Market Size by Application (2016-2027) 8.4 Asia-Pacific Long-acting Injectable Medications Market Size by Region 8.4.1 Asia-Pacific Long-acting Injectable Medications Market Size by Region (2016-2021) 8.4.2 Asia-Pacific Long-acting Injectable Medications Market Size by Region (2022-2027) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Long-acting Injectable Medications Market Size (2016-2027) 9.2 Latin America Long-acting Injectable Medications Market Size by Type 9.2.1 Latin America Long-acting Injectable Medications Market Size by Type (2016-2021) 9.2.2 Latin America Long-acting Injectable Medications Market Size by Type (2022-2027) 9.2.3 Latin America Long-acting Injectable Medications Market Size by Type (2016-2027) 9.3 Latin America Long-acting Injectable Medications Market Size by Application 9.3.1 Latin America Long-acting Injectable Medications Market Size by Application (2016-2021) 9.3.2 Latin America Long-acting Injectable Medications Market Size by Application (2022-2027) 9.3.3 Latin America Long-acting Injectable Medications Market Size by Application (2016-2027) 9.4 Latin America Long-acting Injectable Medications Market Size by Country 9.4.1 Latin America Long-acting Injectable Medications Market Size by Country (2016-2021) 9.4.2 Latin America Long-acting Injectable Medications Market Size by Country (2022-2027) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Long-acting Injectable Medications Market Size (2016-2027) 10.2 Middle East & Africa Long-acting Injectable Medications Market Size by Type 10.2.1 Middle East & Africa Long-acting Injectable Medications Market Size by Type (2016-2021) 10.2.2 Middle East & Africa Long-acting Injectable Medications Market Size by Type (2022-2027) 10.2.3 Middle East & Africa Long-acting Injectable Medications Market Size by Type (2016-2027) 10.3 Middle East & Africa Long-acting Injectable Medications Market Size by Application 10.3.1 Middle East & Africa Long-acting Injectable Medications Market Size by Application (2016-2021) 10.3.2 Middle East & Africa Long-acting Injectable Medications Market Size by Application (2022-2027) 10.3.3 Middle East & Africa Long-acting Injectable Medications Market Size by Application (2016-2027) 10.4 Middle East & Africa Long-acting Injectable Medications Market Size by Country 10.4.1 Middle East & Africa Long-acting Injectable Medications Market Size by Country (2016-2021) 10.4.2 Middle East & Africa Long-acting Injectable Medications Market Size by Country (2022-2027) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 Eli Lilly 11.1.1 Eli Lilly Company Details 11.1.2 Eli Lilly Business Overview 11.1.3 Eli Lilly Long-acting Injectable Medications Introduction 11.1.4 Eli Lilly Revenue in Long-acting Injectable Medications Business (2016-2021) 11.1.5 Eli Lilly Recent Development 11.2 Alkermes 11.2.1 Alkermes Company Details 11.2.2 Alkermes Business Overview 11.2.3 Alkermes Long-acting Injectable Medications Introduction 11.2.4 Alkermes Revenue in Long-acting Injectable Medications Business (2016-2021) 11.2.5 Alkermes Recent Development 11.3 Johnson & Johnson 11.3.1 Johnson & Johnson Company Details 11.3.2 Johnson & Johnson Business Overview 11.3.3 Johnson & Johnson Long-acting Injectable Medications Introduction 11.3.4 Johnson & Johnson Revenue in Long-acting Injectable Medications Business (2016-2021) 11.3.5 Johnson & Johnson Recent Development 11.4 Zogenix 11.4.1 Zogenix Company Details 11.4.2 Zogenix Business Overview 11.4.3 Zogenix Long-acting Injectable Medications Introduction 11.4.4 Zogenix Revenue in Long-acting Injectable Medications Business (2016-2021) 11.4.5 Zogenix Recent Development 11.5 DURECT 11.5.1 DURECT Company Details 11.5.2 DURECT Business Overview 11.5.3 DURECT Long-acting Injectable Medications Introduction 11.5.4 DURECT Revenue in Long-acting Injectable Medications Business (2016-2021) 11.5.5 DURECT Recent Development 11.6 Mapi Pharma 11.6.1 Mapi Pharma Company Details 11.6.2 Mapi Pharma Business Overview 11.6.3 Mapi Pharma Long-acting Injectable Medications Introduction 11.6.4 Mapi Pharma Revenue in Long-acting Injectable Medications Business (2016-2021) 11.6.5 Mapi Pharma Recent Development 11.7 GSK 11.7.1 GSK Company Details 11.7.2 GSK Business Overview 11.7.3 GSK Long-acting Injectable Medications Introduction 11.7.4 GSK Revenue in Long-acting Injectable Medications Business (2016-2021) 11.7.5 GSK Recent Development 11.8 MedinCell 11.8.1 MedinCell Company Details 11.8.2 MedinCell Business Overview 11.8.3 MedinCell Long-acting Injectable Medications Introduction 11.8.4 MedinCell Revenue in Long-acting Injectable Medications Business (2016-2021) 11.8.5 MedinCell Recent Development 11.9 Oakwood Labs 11.9.1 Oakwood Labs Company Details 11.9.2 Oakwood Labs Business Overview 11.9.3 Oakwood Labs Long-acting Injectable Medications Introduction 11.9.4 Oakwood Labs Revenue in Long-acting Injectable Medications Business (2016-2021) 11.9.5 Oakwood Labs Recent Development 11.10 Nanomi 11.10.1 Nanomi Company Details 11.10.2 Nanomi Business Overview 11.10.3 Nanomi Long-acting Injectable Medications Introduction 11.10.4 Nanomi Revenue in Long-acting Injectable Medications Business (2016-2021) 11.10.5 Nanomi Recent Development 11.11 Pharmathen 11.11.1 Pharmathen Company Details 11.11.2 Pharmathen Business Overview 11.11.3 Pharmathen Long-acting Injectable Medications Introduction 11.11.4 Pharmathen Revenue in Long-acting Injectable Medications Business (2016-2021) 11.11.5 Pharmathen Recent Development 11.12 Kashiv BioSciences 11.12.1 Kashiv BioSciences Company Details 11.12.2 Kashiv BioSciences Business Overview 11.12.3 Kashiv BioSciences Long-acting Injectable Medications Introduction 11.12.4 Kashiv BioSciences Revenue in Long-acting Injectable Medications Business (2016-2021) 11.12.5 Kashiv BioSciences Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Long-acting Injectable Medications Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027 Table 2. Key Players of First-generation Table 3. Key Players of Second-generation Table 4. Global Long-acting Injectable Medications Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027 Table 5. Global Long-acting Injectable Medications Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027 Table 6. Global Long-acting Injectable Medications Market Size by Regions (2016-2021) & (US$ Million) Table 7. Global Long-acting Injectable Medications Market Share by Regions (2016-2021) Table 8. Global Long-acting Injectable Medications Forecasted Market Size by Regions (2022-2027) & (US$ Million) Table 9. Global Long-acting Injectable Medications Market Share by Regions (2022-2027) Table 10. Long-acting Injectable Medications Market Trends Table 11. Long-acting Injectable Medications Market Drivers Table 12. Long-acting Injectable Medications Market Challenges Table 13. Long-acting Injectable Medications Market Restraints Table 14. Global Long-acting Injectable Medications Revenue by Players (2016-2021) & (US$ Million) Table 15. Global Long-acting Injectable Medications Market Share by Players (2016-2021) Table 16. Global Top Long-acting Injectable Medications Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Long-acting Injectable Medications as of 2020) Table 17. Ranking of Global Top Long-acting Injectable Medications Companies by Revenue (US$ Million) in 2020 Table 18. Global 5 Largest Players Market Share by Long-acting Injectable Medications Revenue (CR5 and HHI) & (2016-2021) Table 19. Key Players Headquarters and Area Served Table 20. Key Players Long-acting Injectable Medications Product Solution and Service Table 21. Date of Enter into Long-acting Injectable Medications Market Table 22. Mergers & Acquisitions, Expansion Plans Table 23. Global Long-acting Injectable Medications Market Size by Type (2016-2021) (US$ Million) Table 24. Global Long-acting Injectable Medications Revenue Market Share by Type (2016-2021) Table 25. Global Long-acting Injectable Medications Forecasted Market Size by Type (2022-2027) (US$ Million) Table 26. Global Long-acting Injectable Medications Revenue Market Share by Type (2022-2027) & (US$ Million) Table 27. Global Long-acting Injectable Medications Market Size Share by Application (2016-2021) & (US$ Million) Table 28. Global Long-acting Injectable Medications Revenue Market Share by Application (2016-2021) Table 29. Global Long-acting Injectable Medications Forecasted Market Size by Application (2022-2027) (US$ Million) Table 30. Global Long-acting Injectable Medications Revenue Market Share by Application (2022-2027) & (US$ Million) Table 31. North America Long-acting Injectable Medications Market Size by Type (2016-2021) (US$ Million) Table 32. North America Long-acting Injectable Medications Market Size by Type (2022-2027) & (US$ Million) Table 33. North America Long-acting Injectable Medications Market Size by Application (2016-2021) (US$ Million) Table 34. North America Long-acting Injectable Medications Market Size by Application (2022-2027) & (US$ Million) Table 35. North America Long-acting Injectable Medications Market Size by Country (2016-2021) & (US$ Million) Table 36. North America Long-acting Injectable Medications Market Size by Country (2022-2027) & (US$ Million) Table 37. Europe Long-acting Injectable Medications Market Size by Type (2016-2021) (US$ Million) Table 38. Europe Long-acting Injectable Medications Market Size by Type (2022-2027) & (US$ Million) Table 39. Europe Long-acting Injectable Medications Market Size by Application (2016-2021) (US$ Million) Table 40. Europe Long-acting Injectable Medications Market Size by Application (2022-2027) & (US$ Million) Table 41. Europe Long-acting Injectable Medications Market Size by Country (2016-2021) & (US$ Million) Table 42. Europe Long-acting Injectable Medications Market Size by Country (2022-2027) & (US$ Million) Table 43. Asia-Pacific Long-acting Injectable Medications Market Size by Type (2016-2021) (US$ Million) Table 44. Asia-Pacific Long-acting Injectable Medications Market Size by Type (2022-2027) & (US$ Million) Table 45. Asia-Pacific Long-acting Injectable Medications Market Size by Application (2016-2021) (US$ Million) Table 46. Asia-Pacific Long-acting Injectable Medications Market Size by Application (2022-2027) & (US$ Million) Table 47. Asia-Pacific Long-acting Injectable Medications Market Size by Region (2016-2021) & (US$ Million) Table 48. Asia-Pacific Long-acting Injectable Medications Market Size by Region (2022-2027) & (US$ Million) Table 49. Latin America Long-acting Injectable Medications Market Size by Type (2016-2021) (US$ Million) Table 50. Latin America Long-acting Injectable Medications Market Size by Type (2022-2027) & (US$ Million) Table 51. Latin America Long-acting Injectable Medications Market Size by Application (2016-2021) (US$ Million) Table 52. Latin America Long-acting Injectable Medications Market Size by Application (2022-2027) & (US$ Million) Table 53. Latin America Long-acting Injectable Medications Market Size by Country (2016-2021) & (US$ Million) Table 54. Latin America Long-acting Injectable Medications Market Size by Country (2022-2027) & (US$ Million) Table 55. Middle East & Africa Long-acting Injectable Medications Market Size by Type (2016-2021) (US$ Million) Table 56. Middle East & Africa Long-acting Injectable Medications Market Size by Type (2022-2027) & (US$ Million) Table 57. Middle East & Africa Long-acting Injectable Medications Market Size by Application (2016-2021) (US$ Million) Table 58. Middle East & Africa Long-acting Injectable Medications Market Size by Application (2022-2027) & (US$ Million) Table 59. Middle East & Africa Long-acting Injectable Medications Market Size by Country (2016-2021) & (US$ Million) Table 60. Middle East & Africa Long-acting Injectable Medications Market Size by Country (2022-2027) & (US$ Million) Table 61. Eli Lilly Company Details Table 62. Eli Lilly Business Overview Table 63. Eli Lilly Long-acting Injectable Medications Product Table 64. Eli Lilly Revenue in Long-acting Injectable Medications Business (2016-2021) & (US$ Million) Table 65. Eli Lilly Recent Development Table 66. Alkermes Company Details Table 67. Alkermes Business Overview Table 68. Alkermes Long-acting Injectable Medications Product Table 69. Alkermes Revenue in Long-acting Injectable Medications Business (2016-2021) & (US$ Million) Table 70. Alkermes Recent Development Table 71. Johnson & Johnson Company Details Table 72. Johnson & Johnson Business Overview Table 73. Johnson & Johnson Long-acting Injectable Medications Product Table 74. Johnson & Johnson Revenue in Long-acting Injectable Medications Business (2016-2021) & (US$ Million) Table 75. Johnson & Johnson Recent Development Table 76. Zogenix Company Details Table 77. Zogenix Business Overview Table 78. Zogenix Long-acting Injectable Medications Product Table 79. Zogenix Revenue in Long-acting Injectable Medications Business (2016-2021) & (US$ Million) Table 80. Zogenix Recent Development Table 81. DURECT Company Details Table 82. DURECT Business Overview Table 83. DURECT Long-acting Injectable Medications Product Table 84. DURECT Revenue in Long-acting Injectable Medications Business (2016-2021) & (US$ Million) Table 85. DURECT Recent Development Table 86. Mapi Pharma Company Details Table 87. Mapi Pharma Business Overview Table 88. Mapi Pharma Long-acting Injectable Medications Product Table 89. Mapi Pharma Revenue in Long-acting Injectable Medications Business (2016-2021) & (US$ Million) Table 90. Mapi Pharma Recent Development Table 91. GSK Company Details Table 92. GSK Business Overview Table 93. GSK Long-acting Injectable Medications Product Table 94. GSK Revenue in Long-acting Injectable Medications Business (2016-2021) & (US$ Million) Table 95. GSK Recent Development Table 96. MedinCell Company Details Table 97. MedinCell Business Overview Table 98. MedinCell Revenue in Long-acting Injectable Medications Business (2016-2021) & (US$ Million) Table 99. MedinCell Recent Development Table 100. Oakwood Labs Company Details Table 101. Oakwood Labs Business Overview Table 102. Oakwood Labs Long-acting Injectable Medications Product Table 103. Oakwood Labs Revenue in Long-acting Injectable Medications Business (2016-2021) & (US$ Million) Table 104. Oakwood Labs Recent Development Table 105. Nanomi Company Details Table 106. Nanomi Business Overview Table 107. Nanomi Long-acting Injectable Medications Product Table 108. Nanomi Revenue in Long-acting Injectable Medications Business (2016-2021) & (US$ Million) Table 109. Nanomi Recent Development Table 110. Pharmathen Company Details Table 111. Pharmathen Business Overview Table 112. Pharmathen Long-acting Injectable Medications Product Table 113. Pharmathen Revenue in Long-acting Injectable Medications Business (2016-2021) & (US$ Million) Table 114. Pharmathen Recent Development Table 115. Kashiv BioSciences Company Details Table 116. Kashiv BioSciences Business Overview Table 117. Kashiv BioSciences Long-acting Injectable Medications Product Table 118. Kashiv BioSciences Revenue in Long-acting Injectable Medications Business (2016-2021) & (US$ Million) Table 119. Kashiv BioSciences Recent Development Table 120. Research Programs/Design for This Report Table 121. Key Data Information from Secondary Sources Table 122. Key Data Information from Primary Sources List of Figures Figure 1. Global Long-acting Injectable Medications Market Share by Type: 2020 VS 2027 Figure 2. First-generation Features Figure 3. Second-generation Features Figure 4. Global Long-acting Injectable Medications Market Share by Application: 2020 VS 2027 Figure 5. Schizophrenia Case Studies Figure 6. Contraception Case Studies Figure 7. HIV Case Studies Figure 8. Others Case Studies Figure 9. Long-acting Injectable Medications Report Years Considered Figure 10. Global Long-acting Injectable Medications Market Size (US$ Million), Year-over-Year: 2016-2027 Figure 11. Global Long-acting Injectable Medications Market Size (US$ Million), 2016 VS 2021 VS 2027 Figure 12. Global Long-acting Injectable Medications Market Share by Regions: 2020 VS 2027 Figure 13. Global Long-acting Injectable Medications Market Share by Regions (2022-2027) Figure 14. Global Long-acting Injectable Medications Market Share by Players in 2020 Figure 15. Global Top Long-acting Injectable Medications Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Long-acting Injectable Medications as of 2020 Figure 16. The Top 10 and 5 Players Market Share by Long-acting Injectable Medications Revenue in 2020 Figure 17. Global Long-acting Injectable Medications Revenue Market Share by Type (2016-2021) Figure 18. Global Long-acting Injectable Medications Revenue Market Share by Type (2022-2027) Figure 19. North America Long-acting Injectable Medications Market Size YoY Growth (2016-2027) & (US$ Million) Figure 20. North America Long-acting Injectable Medications Market Share by Type (2016-2027) Figure 21. North America Long-acting Injectable Medications Market Share by Application (2016-2027) Figure 22. North America Long-acting Injectable Medications Market Share by Country (2016-2027) Figure 23. United States Long-acting Injectable Medications Market Size YoY Growth (2016-2027) & (US$ Million) Figure 24. Canada Long-acting Injectable Medications Market Size YoY Growth (2016-2027) & (US$ Million) Figure 25. Europe Long-acting Injectable Medications Market Size YoY Growth (2016-2027) & (US$ Million) Figure 26. Europe Long-acting Injectable Medications Market Share by Type (2016-2027) Figure 27. Europe Long-acting Injectable Medications Market Share by Application (2016-2027) Figure 28. Europe Long-acting Injectable Medications Market Share by Country (2016-2027) Figure 29. Germany Long-acting Injectable Medications Market Size YoY Growth (2016-2027) & (US$ Million) Figure 30. France Long-acting Injectable Medications Market Size YoY Growth (2016-2027) & (US$ Million) Figure 31. U.K. Long-acting Injectable Medications Market Size YoY Growth (2016-2027) & (US$ Million) Figure 32. Italy Long-acting Injectable Medications Market Size YoY Growth (2016-2027) & (US$ Million) Figure 33. Russia Long-acting Injectable Medications Market Size YoY Growth (2016-2027) & (US$ Million) Figure 34. Nordic Long-acting Injectable Medications Market Size YoY Growth (2016-2027) & (US$ Million) Figure 35. Asia-Pacific Long-acting Injectable Medications Market Size YoY Growth (2016-2027) & (US$ Million) Figure 36. Asia-Pacific Long-acting Injectable Medications Market Share by Type (2016-2027) Figure 37. Asia-Pacific Long-acting Injectable Medications Market Share by Application (2016-2027) Figure 38. Asia-Pacific Long-acting Injectable Medications Market Share by Region (2016-2027) Figure 39. China Long-acting Injectable Medications Market Size YoY Growth (2016-2027) & (US$ Million) Figure 40. Japan Long-acting Injectable Medications Market Size YoY Growth (2016-2027) & (US$ Million) Figure 41. South Korea Long-acting Injectable Medications Market Size YoY Growth (2016-2027) & (US$ Million) Figure 42. Southeast Asia Long-acting Injectable Medications Market Size YoY Growth (2016-2027) & (US$ Million) Figure 43. India Long-acting Injectable Medications Market Size YoY Growth (2016-2027) & (US$ Million) Figure 44. Australia Long-acting Injectable Medications Market Size YoY Growth (2016-2027) & (US$ Million) Figure 45. Latin America Long-acting Injectable Medications Market Size YoY Growth (2016-2027) & (US$ Million) Figure 46. Latin America Long-acting Injectable Medications Market Share by Type (2016-2027) Figure 47. Latin America Long-acting Injectable Medications Market Share by Application (2016-2027) Figure 48. Latin America Long-acting Injectable Medications Market Share by Country (2016-2027) Figure 49. Mexico Long-acting Injectable Medications Market Size YoY Growth (2016-2027) & (US$ Million) Figure 50. Brazil Long-acting Injectable Medications Market Size YoY Growth (2016-2027) & (US$ Million) Figure 51. Middle East & Africa Long-acting Injectable Medications Market Size YoY Growth (2016-2027) & (US$ Million) Figure 52. Middle East & Africa Long-acting Injectable Medications Market Share by Type (2016-2027) Figure 53. Middle East & Africa Long-acting Injectable Medications Market Share by Application (2016-2027) Figure 54. Middle East & Africa Long-acting Injectable Medications Market Share by Country (2016-2027) Figure 55. Turkey Long-acting Injectable Medications Market Size YoY Growth (2016-2027) & (US$ Million) Figure 56. Saudi Arabia Long-acting Injectable Medications Market Size YoY Growth (2016-2027) & (US$ Million) Figure 57. UAE Long-acting Injectable Medications Market Size YoY Growth (2016-2027) & (US$ Million) Figure 58. Eli Lilly Revenue Growth Rate in Long-acting Injectable Medications Business (2016-2021) Figure 59. Alkermes Revenue Growth Rate in Long-acting Injectable Medications Business (2016-2021) Figure 60. Johnson & Johnson Revenue Growth Rate in Long-acting Injectable Medications Business (2016-2021) Figure 61. Zogenix Revenue Growth Rate in Long-acting Injectable Medications Business (2016-2021) Figure 62. DURECT Revenue Growth Rate in Long-acting Injectable Medications Business (2016-2021) Figure 63. Mapi Pharma Revenue Growth Rate in Long-acting Injectable Medications Business (2016-2021) Figure 64. GSK Revenue Growth Rate in Long-acting Injectable Medications Business (2016-2021) Figure 65. MedinCell Revenue Growth Rate in Long-acting Injectable Medications Business (2016-2021) Figure 66. Oakwood Labs Revenue Growth Rate in Long-acting Injectable Medications Business (2016-2021) Figure 67. Nanomi Revenue Growth Rate in Long-acting Injectable Medications Business (2016-2021) Figure 68. Pharmathen Revenue Growth Rate in Long-acting Injectable Medications Business (2016-2021) Figure 69. Kashiv BioSciences Revenue Growth Rate in Long-acting Injectable Medications Business (2016-2021) Figure 70. Bottom-up and Top-down Approaches for This Report Figure 71. Data Triangulation Figure 72. Key Executives Interviewed

Eli Lilly Alkermes Johnson & Johnson Zogenix DURECT Mapi Pharma GSK MedinCell Oakwood Labs Nanomi Pharmathen Kashiv BioSciences